| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |